Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Enliven Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 61
- −2 vs. Q2 2023
- Shares held
- 39.1M
- −49.9K (−0.1%) vs. Q2 2023
- Total value
- $533.8M
- −$264.2M (−33.1%) vs. Q2 2023
- New holders
- 6
- 22 more added
- Sold out
- 8
- 22 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 8,998,338 | $122.9M | 2.84% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 5,160,975 | $70.5M | 20.29% | −637,500−11.0% | Reduced |
| FMR LLC | 3,676,213 | $50.2M | 0.00% | −325,398−8.1% | Reduced |
| VR Adviser, LLC | 2,954,902 | $40.4M | 4.25% | +724,775+32.5% | Added |
| Commodore Capital LP | 2,901,816 | $39.6M | 4.63% | +553,544+23.6% | Added |
| Citadel Advisors LLC | 2,351,491 | $32.1M | 0.03% | +55,281+2.4% | Added |
| Fairmount Funds Management LLC | 2,131,369 | $29.1M | 3.50% | +6,744+0.3% | Added |
| Ra Capital Management, L.P. | 2,122,465 | $29.0M | 0.57% | 00.0% | Unchanged |
| BlackRock Inc. | 1,567,532 | $21.4M | 0.00% | +21,057+1.4% | Added |
| Cormorant Asset Management, LP | 1,216,712 | $16.6M | 0.97% | −719,421−37.2% | Reduced |
| Vanguard Group Inc | 1,151,817 | $15.7M | 0.00% | +9,313+0.8% | Added |
| Frazier Life Sciences Management, L.P. | 1,050,483 | $14.3M | 0.95% | +219,500+26.4% | Added |
| Boxer Capital, LLC | 646,058 | $8.83M | 0.47% | −64,586−9.1% | Reduced |
| State Street Corp | 470,852 | $6.43M | 0.00% | +4,601+1.0% | Added |
| Geode Capital Management, LLC | 432,972 | $5.92M | 0.00% | +18,528+4.5% | Added |
| Woodline Partners LP | 395,686 | $5.41M | 0.06% | +395,686 | New |
| Logos Global Management LP | 307,076 | $4.19M | 0.60% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 276,416 | $3.77M | 0.00% | −94,578−25.5% | Reduced |
| Northern Trust Corp | 194,534 | $2.66M | 0.00% | −1,406−0.7% | Reduced |
| Charles Schwab Investment Management Inc | 156,631 | $2.14M | 0.00% | +94,169+150.8% | Added |
| HighVista Strategies LLC | 124,587 | $1.70M | 0.79% | +3,514+2.9% | Added |
| Acuta Capital Partners, LLC | 103,600 | $1.42M | 1.03% | −900−0.9% | Reduced |
| Nuveen Asset Management, LLC | 86,967 | $1.19M | 0.00% | +22,272+34.4% | Added |
| Bank of New York Mellon Corp | 80,759 | $1.10M | 0.00% | −165−0.2% | Reduced |
| BML Capital Management, LLC | 50,000 | $683.0K | 0.63% | −24,232−32.6% | Reduced |
| Swiss National Bank | 40,673 | $555.6K | 0.00% | −8,500−17.3% | Reduced |
| Rhumbline Advisers | 34,363 | $469.4K | 0.00% | −433−1.2% | Reduced |
| Morgan Stanley | 33,970 | $464.0K | 0.00% | +649+1.9% | Added |
| JBF Capital, Inc. | 27,006 | $368.9K | 0.08% | −23,044−46.0% | Reduced |
| JPMorgan Chase & Co | 26,495 | $361.9K | 0.00% | −4,160−13.6% | Reduced |
| Bank of America Corp | 23,106 | $315.6K | 0.00% | +6,063+35.6% | Added |
| Credit Suisse AG | 22,850 | $312.1K | 0.00% | −1,205−5.0% | Reduced |
| California State Teachers Retirement System | 21,509 | $293.8K | 0.00% | −6,097−22.1% | Reduced |
| Legal & General Group Plc | 19,665 | $268.6K | 0.00% | +1,610+8.9% | Added |
| State of Wisconsin Investment Board | 18,948 | $258.8K | 0.00% | −3,234−14.6% | Reduced |
| Invesco Ltd. | 18,766 | $256.3K | 0.00% | +18,766 | New |
| Bridgeway Capital Management, LLC | 17,950 | $245.2K | 0.01% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 17,690 | $241.6K | 0.00% | −9,596−35.2% | Reduced |
| Alliancebernstein L.P. | 14,330 | $195.7K | 0.00% | +14,330 | New |
| Barclays PLC | 13,629 | $186.2K | 0.00% | −1,198−8.1% | Reduced |
| AQR Capital Management LLC | 12,972 | $177.2K | 0.00% | +12,972 | New |
| MetLife Investment Management | 12,345 | $168.6K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 11,649 | $159.1K | 0.00% | +414+3.7% | Added |
| SG Americas Securities, LLC | 11,460 | $157.0K | 0.00% | +11,460 | New |
| Mirae Asset Global Investments Co., Ltd. | 11,276 | $154.0K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 10,890 | $148.8K | 0.00% | +1,559+16.7% | Added |
| New York State Common Retirement Fund | 9,453 | $129.1K | 0.00% | +253+2.8% | Added |
| Tower Research Capital LLC (TRC) | 6,755 | $92.3K | 0.00% | +5,373+388.8% | Added |
| Exchange Traded Concepts, LLC | 6,500 | $88.8K | 0.00% | −434−6.3% | Reduced |
| Wells Fargo & Company | 5,740 | $78.4K | 0.00% | −3,130−35.3% | Reduced |
| Royal Bank of Canada | 4,707 | $65.0K | 0.00% | +1,632+53.1% | Added |
| Citigroup Inc | 3,347 | $45.7K | 0.00% | −7,476−69.1% | Reduced |
| Amalgamated Bank | 2,270 | $31.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,000 | $27.3K | 0.00% | +1,000+100.0% | Added |
| Ameritas Investment Partners, Inc. | 1,928 | $26.3K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,279 | $17.5K | 0.00% | 00.0% | Unchanged |
| Allspring Global Investments Holdings, LLC | 566 | $7.73K | 0.00% | +566 | New |
| UBS Group AG | 105 | $1.43K | 0.00% | +24+29.6% | Added |
| Baystate Wealth Management LLC | 50 | $683 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 9 | $123 | 0.00% | −7−43.8% | Reduced |
| Covestor Ltd | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 0 | $0 | 0.00% | −191,893−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −36,150−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −23,762−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −11,685−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,531−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −9,900−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −1,375−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −33,550−100.0% | Sold out |